Journals / Journal of Turkish Spinal Surgery / 2019 / Cilt: 30 - Sayı: 4

USE OF BETA-TRICALCIUM PHOSPHATE WITH BONE MARROW ASPIRATE AS A BONE GRAFT SUBSTITUTE IN POSTEROLATERAL LUMBAR FUSION

Pages
227–230
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The bony fusion rate of PLF involving ß-TCP and BMA was relatively high at 72.7%. ß-TCP is an effective and appropriate material for PLF in the lumbar area when used with BMA, and approximately 10 mL of ß-TCP per vertebral segment is sufficient.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Retrospective clinical study.
📊
Key Findings & Data:This study aimed to determine the bony fusion rate of posterior lumbar fusion (PLF) involving betatricalcium phosphate (ß-TCP) and bone marrow aspirate (BMA).
💡
Conclusion & Impact:Conclusion: The bony fusion rate of PLF involving ß-TCP and BMA was relatively high at 72.7%. ß-TCP is an effective and appropriate material for PLF in the lumbar area when used with BMA, and approximately 10 mL of ß-TCP per vertebral segment is sufficient.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: Retrospective clinical study. This study aimed to determine the bony fusion rate of posterior lumbar fusion (PLF) involving betatricalcium phosphate (ß-TCP) and bone marrow aspirate (BMA). Bone fusion remains the main component of primary surgical approach for several spinal disorders. Spine surgeons face the need to make crucial decisions regarding bone graft selection in each case. Materials and Methods: The study included 33 patients (21 female and 12 male patients) who underwent posterior lumbar pedicle screw fixation and fusion using ß-TCP as a bone substitute. The mean patient age was 58.35 (range=35-81) years. Results: The mean follow-up duration was 23.45 months. Solid bony fusion at the lateral side of the lumbar region between transverse processes was noted on radiography in 24 patients (72.7%), bony bridging between adjacent transverse processes in 5 patients (15.2%), and no new bone formation in the remaining 4 patients (12.1%). Conclusion: The bony fusion rate of PLF involving ß-TCP and BMA was relatively high at 72.7%. ß-TCP is an effective and appropriate material for PLF in the lumbar area when used with BMA, and approximately 10 mL of ß-TCP per vertebral segment is sufficient.

🔖

Cite This Article

TUNCER, C., POLAT, Ö., ER, U. (2019). USE OF BETA-TRICALCIUM PHOSPHATE WITH BONE MARROW ASPIRATE AS A BONE GRAFT SUBSTITUTE IN POSTEROLATERAL LUMBAR FUSION. Journal of Turkish Spinal Surgery, Cilt: 30 - Sayı: 4, 227–230. https://ajindex.com/articles/190787

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Dai LY, Jiang LS. Single-level instrumented posterolateral fusion of lumbar spine with beta-tricalcium phosphate versus autograft: a prospective, randomized study with 3-year follow-up. Spine (Phila Pa 1976) 2008;33:1299-304
  2. Finkemeier CG. Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am 2002;84-A:454-64
  3. Guigui P, Ferrero E. Surgical treatment of degenerative spondylolisthesis. Orthop Traumatol Surg Res 2017;103:S11-S20
  4. Hsu WK, Nickoli MS, Wang JC, Lieberman JR, An HS, Yoon ST, et al. Improving the clinical evidence of bone graft substitute technology in lumbar spine surgery. Global Spine J 2012;2:239-48
  5. Lee CS, Hwang CJ, Lee DH, Kim YT, Lee HS. Fusion rates of instrumentedlLumbar spinal arthrodesis according to surgical approach: A systematic review of randomized trials. Clin Orthop Surg 201;3:39-47
  6. Lindley EM, Barton C, Blount T, Burger EL, Cain CM, Seim HB, et al. An analysis of spine fusion outcomes in sheep pre-clinical models. Eur Spine J 2017;26:228-39
  7. Lerner T, Bullmann V, Schulte TL, Schneider M, Liljenqvist U. A level-1 pilot study to evaluate of ultraporous beta-tricalcium phosphate as a graft extender in the posterior correction of adolescent idiopathic scoliosis. Eur Spine J 2009;18:170-9
  8. McLain R F, Fleming J E, Boehm C A, Muschler G F. Aspiration of osteoprogenitor cells for augmenting spinal fusion: comparison of progenitor cell concentrations from the vertebral body and iliac crest. J Bone Joint Surg Am 2005;87:2655-61
  9. Park JJ, Hershman SH, Kim YH. Updates in the use of bone grafts in the lumbar spine. Bulletin of the Hospital for Joint Diseases 2013;71:39-48
  10. Thaler M, Lechner R, Gstöttner M, Kobel C, Bach C. The use of beta-tricalcium phosphate and bone marrow aspirate as a bone graft substitute in posterior lumbar interbody fusion. Eur Spine J 2013;22:1173-82
  11. Weinstein JN, Lurie JD, Olson PR, Bronner KK, Fisher ES. United States’ trends and regional variations in lumbar spine surgery. Spine 2006;31:2707-14
  12. Zhang Q, Yuan Z, Zhou M, Liu H, Xu Y, Ren Y. A comparison of posterior lumbar interbody fusion and transforaminal lumbar interbody fusion: a literature review and meta-analysis. BMC Musculoskelet Disord 2014;15:367-75.